Choreo LLC’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275K Buy
1,096
+101
+10% +$25.1K ﹤0.01% 1302
2025
Q4
$276K Sell
995
-80
-7% -$21.9K ﹤0.01% 1268
2025
Q3
$282K Buy
+1,075
New +$261K ﹤0.01% 1265
2025
Q1
Sell
-628
Closed -$206K 1612
2024
Q4
$206K Sell
628
-341
-35% -$107K ﹤0.01% 1412
2024
Q3
$291K Buy
969
+244
+34% +$74.7K ﹤0.01% 1223
2024
Q2
$234K Buy
+725
New +$256K ﹤0.01% 1239
2022
Q1
Sell
-463
Closed -$217K 251
2021
Q4
$217K Sell
463
-45
-9% -$19.4K 0.01% 220
2021
Q3
$216K Buy
+508
New +$214K 0.01% 201

Other funds holding WST

Choreo LLC's WST Position: Q1 2026 in Review

Choreo LLC increased its West Pharmaceutical (WST) stake by 10% in Q1 2026, buying an estimated $25.1K and bringing the position to 1,096 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #1302.

Choreo LLC first reported a position in WST in Q3 2021 and has held it in 8 quarters since. The position peaked at $291K in Q3 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Choreo LLC held 1,096 shares of West Pharmaceutical worth $275K as of Q1 2026.
  • Choreo LLC bought 101 West Pharmaceutical shares in Q1 2026, an estimated $25.1K.
  • West Pharmaceutical made up ﹤0.01% of Choreo LLC's portfolio in Q1 2026, its #1302 holding.
  • Choreo LLC first reported a position in West Pharmaceutical in Q3 2021 and has held it in 8 quarters since.
  • Choreo LLC's West Pharmaceutical position peaked at $291K in Q3 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.